The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.
View details for DOI 10.1182/blood-2012-05-423236
View details for Web of Science ID 000313113300011
View details for PubMedID 22821764
View details for PubMedCentralID PMC3512228